Screening of inhibitors as potential remedial against Ebolavirus infection: pharmacophore-based approach

References

• Balaji, R., Sabitha, K., & Thangarajan, R. (2016). Molecular modeling and docking of small molecule inhibitors against NEK2. Bioinformation, 12(2), 62–68. doi:10.6026/97320630012062
   PubMed Web of Science ®Google Scholar
• Choubey, S. K., Mariadasse, R., Rajendran, S., & Jeyaraman, J. (2016). Identification of novel histone deacetylase 1 inhibitors by combined pharmacophore modeling, 3D-QSAR analysis, in silico screening and Density Functional Theory (DFT) approaches. Journal of Molecular Structure, 1125, 391–404. doi:10.1016/j.molstruc.2016.06.082
   Web of Science ®Google Scholar
• De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016). Role of molecular dynamics and related methods in drug discovery. Journal of Medicinal Chemistry, 59(9), 4035–4061. doi:10.1021/acs.jmedchem.5b01684
   PubMed Web of Science ®Google Scholar
• Ekins, S., Freundlich, J. S., & Coffee, M. (2014). A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus. F1000Research, 14 (12), 3–277. doi:10.12688/f1000research.5741.2
   Google Scholar
• Entezari Heravi, Y., Sereshti, H., Saboury, A. A., Ghasemi, J., Amirmostofian, M., & Supuran, C. T. (2017). 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole–benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 688–700. doi:10.1080/14756366.2016.1241781
   PubMed Web of Science ®Google Scholar
• Feldmann, H., & Geisbert, T. W. (2011). Ebola haemorrhagic fever. The Lancet, 377(9768), 849–862. doi:10.1016/S0140-6736(10)60667-8
   PubMed Web of Science ®Google Scholar
• Goeijenbier, M., van Kampen, J. J. A., Reusken, C. B. E. M., Koopmans, M. P. G., & van Gorp, E. C. M. (2014). Ebola virus disease: A review on epidemiology, symptoms, treatment and pathogenesis. The Netherlands Journal of Medicine, 72(9), 442–448.
   PubMed Web of Science ®Google Scholar
• Karthick, V., Nagasundaram, N., Doss, C. G. P., Chakraborty, C., Siva, R., Lu, A., … Zhu, H. (2016). Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus. Infectious Diseases of Poverty, 5(1), 1–10. doi:10.1186/s40249-016-0105-1
   PubMed Web of Science ®Google Scholar
• Kim, K. H., Kim, N. D., & Seong, B. L. (2010). Pharmacophore-based virtual screening: A review of recent applications. Expert Opinion on Drug Discovery, 5(3), 205–222. doi:10.1517/17460441003592072
   PubMed Web of Science ®Google Scholar
• Kirubakaran, P., & Karthikeyan, M. (2013). Pharmacophore modeling, 3D-QSAR and DFT studies of IWR small-molecule inhibitors of Wnt response. Journal of Receptors and Signal Transduction, 33(5), 276–285. doi:10.3109/10799893.2013.822888
   PubMed Web of Science ®Google Scholar
• Mali, S. N., & Chaudhari, H. K. (2019). Molecular modelling studies on adamantane-based Ebola virus GP-1 inhibitors using docking, pharmacophore and 3D-QSAR. SAR and QSAR in Environmental Research, 30(3), 161–180. doi:10.1080/1062936X.2019.1573377
   PubMed Web of Science ®Google Scholar
• Martin, B., Reynard, O., Volchkov, V., & Decroly, E. (2018). Filovirus proteins for antiviral drug discovery: Structure/function of proteins involved in assembly and budding. Antiviral Research, 150, 183–192. doi:10.1016/j.antiviral.2017.12.022
   PubMed Web of Science ®Google Scholar
• Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer Aided-Drug Design, 7(2), 146–157. doi:10.2174/157340911795677602
   PubMed Web of Science ®Google Scholar
• Nasution, M. A. F., Toepak, E. P., Alkaff, A. H., & Tambunan, U. S. F. (2018). Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): A computational approach to discover new drug for combating Ebola. BMC Bioinformatics, 19(S14), 419. doi:10.1186/s12859-018-2387-8
   PubMed Web of Science ®Google Scholar
• Onawole, A. T., Kolapo, T. U., Sulaiman, K. O., & Adegoke, R. O. (2018). Structure based virtual screening of the Ebola virus trimeric glycoprotein using consensus scoring. Computational Biology and Chemistry, 72, 170–180. doi:10.1016/j.compbiolchem.2017
   PubMed Web of Science ®Google Scholar
• Panwar, U., & Singh, S. K. (2018). Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between hiv-1 integrase and human lens epithelium-derived growth factor (Ledgf/p75). Journal of Biomolecular Structure and Dynamics, 36(12), 3199–3217. doi:10.1080/07391102.2017.1384400
   PubMed Web of Science ®Google Scholar
• Paramjit, K., Vikas, S., & Vipin, K. (2012). Pharmacophore modelling and 3D-QSAR studies on phenylpyrazinones as corticotropin-releasing factor 1 receptor antagonists. International Journal of Medicinal Chemistry, 2012, 452325. doi:10.1155/2012/452325
   PubMedGoogle Scholar
• Rai, A., Aboumanei, M. H., Verma, S. P., Kumar, S., & Raj, V. (2017). Molecular docking, pharmacophore, and 3D-QSAR approach: Can adenine derivatives exhibit significant inhibitor towards Ebola virus. The Open Medicinal Chemistry Journal, 11(1), 127–137. doi:10.2174/1874104501711010127
   PubMedGoogle Scholar
• Rajak, H., Jain, D. K., Singh, A., Sharma, A. K., & Dixit, A. (2015). Ebola virus disease: Past, present and future. Asian Pacific Journal of Tropical Biomedicine, 5(5), 337–343. doi:10.1016/S2221-1691(15)30365-8
   Google Scholar
• Salmaso, V., & Moro, S. (2018). Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview. Front. Pharmacol, 9, 923. doi:10.3389/fphar.2018.00923
   PubMed Web of Science ®Google Scholar
• Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W., Jr. (2014). Computational Methods in Drug Discovery. Pharmacological Reviews, 66(1), 334–395. doi:10.1124/pr.112.007336
   PubMed Web of Science ®Google Scholar
• Sulaiman, K. O., Kolapo, T. U., Onawole, A. T., Islam, M. A., Adegoke, R. O., & Badmus, S. O. (2019). Molecular dynamics and combined docking studies for the identification of Zaire Ebola virus inhibitors. Journal of Biomolecular Structure and Dynamics, 37(12), 3029–3040. doi:10.1080/07391102.2018.1506362
   PubMed Web of Science ®Google Scholar
• Sun, Y., Guo, Y., & Lou, Z. (2012). A versatile building block: The structures and functions of negative-sense single-stranded RNA virus nucleocapsid proteins. Protein & Cell, 3(12), 893–902. doi:10.1007/s13238-012-2087-5
   PubMed Web of Science ®Google Scholar
• Suryanarayanan, V., Kumar Singh, S., Kumar Tripathi, S., Selvaraj, C., Konda Reddy, K., & Karthiga, A. (2013). A three-dimensional chemical phase pharmacophore mapping, QSAR modelling and electronic feature analysis of benzofuran salicylic acid derivatives as LYP inhibitors. SAR and QSAR in Environmental Research, 24(12), 1025–1040. doi:10.1080/1062936X.2013.821421
   PubMed Web of Science ®Google Scholar
• Vetter, P., Fischer, W. A., Schibler, M., Jacobs, M., Bausch, D. G., & Kaiser, L. (2016). Ebola virus shedding and transmission: Review of current evidence. Journal of Infectious Diseases, 214(Suppl 3), S177–S184. doi:10.1093/infdis/jiw254
   PubMed Web of Science ®Google Scholar
• Vijaya Prabhu, S., & Singh, S. K. (2018). Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno[2,3-b]pyridines negative allosteric modulators of mGluR5. Journal of Receptors and Signal Transduction, 38(3), 225–239. doi:10.1080/10799893.2018.1476542
   PubMed Web of Science ®Google Scholar
• Watanabe, S., Noda, T., & Kawaoka, Y. (2006). Functional mapping of the nucleoprotein of Ebola virus. Journal of Virology, 80(8), 3743–3751. doi:10.1128/JVI.80.8.3743-3751.2006
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (2018). Ebola situation reports: Democratic Republic of the Congo. Seminars in Immunology, 39, 65–72.
   PubMed Web of Science ®Google Scholar
• Zhang, T., Zhai, M., Ji, J., Zhang, J., Tian, Y., & Liu, X. (2017). Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies. Bioorganic and Medicinal Chemistry Letters, 27(11), 2364–2368. doi:10.1016/j.bmcl.2017.04.028
   PubMed Web of Science ®Google Scholar